Mr David Thurtle and Mr Vincent J Gnanapragasam from The University of Cambridge are working on a new individualised prognostic model called ‘PREDICT: Prostate’ which aims to improve treatment decision-making for men diagnosed with prostate cancer. They are seeking help from health care providers who work in prostate cancer, to complete this survey which will help inform their ongoing work.
Decision making for men with newly diagnosed prostate cancer is a complex process with many variables to be considered. The key question is how beneficial treatment is in the context of an individual’s disease type, prognosis and personal competing risks from other co-morbidities. Current tools to assist in decision-making mainly rely on broad heterogeneous classification systems often derived from radically-treated and screened cohorts.
We have developed a new individualised prognostic model called ‘PREDICT: Prostate’ which seeks to address the gaps in the current decision-making paradigm.
Key aspects of our model include:
The first publication and launch of the free website will follow later this year.
We are seeking help from health care providers who see men with prostate cancer to kindly take part in a short survey assessing the potential role, value and impact of the model on their own practice in counselling men:
https://cambridge.eu.qualtrics.com/jfe/form/SV_3jyLWxG8EkpZepT
We will also be presenting PREDICT: Prostate at the BAUS conference in June 2018 – please do visit our stall in the exhibition hall where the full website will be demonstrated.
We are grateful to The Urology Foundation and The Evelyn Trust for their funding support.
Thank you in advance for your participation. Comments would be gratefully received to:
Mr David Thurtle: dt433@cam.ac.uk
Academic Clinical Fellow and Project Lead
Mr Vincent J Gnanapragasam: vjg29@cam.ac.uk
University Lecturer and Honorary Consultant Urologist
